Robin Hofmann

28PUBLICATIONS
75CO-AUTHORS
Respiratory diseasesCardiology (incl. cardiovascular diseases)NanomedicineEpidemiological modellingHuman impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Apr 08, 2026
Prognostic Value of Impaired Spirometry in Patients with Myocardial Infarction: A Longitudinal Study of Two European Cohorts.

Josefin Sundh, William A E Parker, Jonas Oldgren

|Aug 31, 2025
Long-term effectiveness of ACE inhibitors or angiotensin receptor blockers in myocardial infarction with preserved left ventricular ejection fraction.

Anna B C Humphreys, Bertil Lindahl, Anita Berglund

|Jul 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI Trial.

Robert F Storey, John Deanfield, Stefan James

|May 12, 2025
Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".

Christian Reitan, Pontus Andell, Robin Hofmann

|Jan 15, 2025
The prognostic value of global longitudinal strain in patients with myocardial infarction and preserved ejection fraction: a prespecified substudy of the REDUCE-AMI trial.

Katarina Mars, Robin Hofmann, Martin Jonsson

|Dec 17, 2024
From Crisis to Complications: A Nationwide Cohort Study Assessing One-Year Cardiovascular and Thromboembolic Risks After Severe COVID-19 Compared to Matched Controls.

Andreas Liliequist, Per Svensson, Robin Hofmann

Pageof 5

Frequent Collaborators

9 joint publications

Tomas Jernberg

7 joint publications

Katarina Mars

6 joint publications

Claes Held

5 joint publications

Sophia Humphries